News
Paras Biopharmaceuticals Successfully Develops Cytofold StructQuant� Technology for Cytoplasmic Disulphide Formation, (for Active Folding) for Complex Therapeutic Protein
oulu, Finland, September 10, 2019 –(PR.com)– Paras Biopharmaceuticals Finland Oy is pleased to announce that its proprietary technology, Cytofold StructQuant�, is established...